These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 2875893)

  • 1. The effects of 3,4-methylenedioxymethamphetamine (MDMA) and 3,4-methylenedioxyamphetamine (MDA) on monoaminergic systems in the rat brain.
    Stone DM; Stahl DC; Hanson GR; Gibb JW
    Eur J Pharmacol; 1986 Aug; 128(1-2):41-8. PubMed ID: 2875893
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of amphetamine-like designer drugs on monoaminergic systems in rat brain.
    Gibb JW; Stone DM; Stahl DC; Hanson GR
    NIDA Res Monogr; 1987; 76():316-21. PubMed ID: 2449619
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of N-ethyl-3,4-methylenedioxyamphetamine (MDE) on central serotonergic and dopaminergic systems of the rat.
    Johnson M; Hanson GR; Gibb JW
    Biochem Pharmacol; 1987 Dec; 36(23):4085-93. PubMed ID: 2446629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of 3,4-methylenedioxyamphetamine and 3,4-methylenedioxymethamphetamine isomers on central serotonergic, dopaminergic and nigral neurotensin systems of the rat.
    Johnson M; Letter AA; Merchant K; Hanson GR; Gibb JW
    J Pharmacol Exp Ther; 1988 Mar; 244(3):977-82. PubMed ID: 2472482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of the neurotoxic potential of methylenedioxyamphetamine (MDA) and its N-methylated and N-ethylated derivatives.
    Stone DM; Johnson M; Hanson GR; Gibb JW
    Eur J Pharmacol; 1987 Feb; 134(2):245-8. PubMed ID: 2883012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 3,4-Methylenedioxymethamphetamine and 3,4-methylenedioxyamphetamine destroy serotonin terminals in rat brain: quantification of neurodegeneration by measurement of [3H]paroxetine-labeled serotonin uptake sites.
    Battaglia G; Yeh SY; O'Hearn E; Molliver ME; Kuhar MJ; De Souza EB
    J Pharmacol Exp Ther; 1987 Sep; 242(3):911-6. PubMed ID: 2443644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immediate and long-term effects of 3,4-methylenedioxymethamphetamine on serotonin pathways in brain of rat.
    Stone DM; Merchant KM; Hanson GR; Gibb JW
    Neuropharmacology; 1987 Dec; 26(12):1677-83. PubMed ID: 2893986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of (+-)3,4-methylenedioxymethamphetamine (MDMA) on brain dopaminergic activity in rats.
    Matthews RT; Champney TH; Frye GD
    Pharmacol Biochem Behav; 1989 Aug; 33(4):741-7. PubMed ID: 2575758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of endogenous dopamine in the central serotonergic deficits induced by 3,4-methylenedioxymethamphetamine.
    Stone DM; Johnson M; Hanson GR; Gibb JW
    J Pharmacol Exp Ther; 1988 Oct; 247(1):79-87. PubMed ID: 2902215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A pharmacokinetic analysis of 3,4-methylenedioxymethamphetamine effects on monoamine concentrations in brain dialysates.
    Hiramatsu M; DiStefano E; Chang AS; Cho AK
    Eur J Pharmacol; 1991 Nov; 204(2):135-40. PubMed ID: 1725282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term alteration in the central monoaminergic systems of the rat by 2,4,5-trihydroxyamphetamine but not by 2-hydroxy-4,5-methylenedioxymethamphetamine or 2-hydroxy-4,5-methylenedioxyamphetamine.
    Elayan I; Gibb JW; Hanson GR; Foltz RL; Lim HK; Johnson M
    Eur J Pharmacol; 1992 Oct; 221(2-3):281-8. PubMed ID: 1358654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MDMA transiently alters biogenic amines and metabolites in mouse brain and heart.
    Steele TD; Nichols DE; Yim GK
    Pharmacol Biochem Behav; 1989 Oct; 34(2):223-7. PubMed ID: 2576134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurochemical and neurohistological alterations in the rat and monkey produced by orally administered methylenedioxymethamphetamine (MDMA).
    Slikker W; Ali SF; Scallet AC; Frith CH; Newport GD; Bailey JR
    Toxicol Appl Pharmacol; 1988 Jul; 94(3):448-57. PubMed ID: 2456631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of flunarizine and nimodipine on the decrease in tryptophan hydroxylase activity induced by methamphetamine and 3,4-methylenedioxymethamphetamine.
    Johnson M; Mitros K; Stone DM; Zobrist R; Hanson GR; Gibb JW
    J Pharmacol Exp Ther; 1992 May; 261(2):586-91. PubMed ID: 1374469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term central 5-HT depletions resulting from repeated administration of MDMA enhances the effects of single administration of MDMA on schedule-controlled behavior of rats.
    Li AA; Marek GJ; Vosmer G; Seiden LS
    Pharmacol Biochem Behav; 1989 Jul; 33(3):641-8. PubMed ID: 2573905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A study of the mechanism of MDMA ('ecstasy')-induced neurotoxicity of 5-HT neurones using chlormethiazole, dizocilpine and other protective compounds.
    Colado MI; Green AR
    Br J Pharmacol; 1994 Jan; 111(1):131-6. PubMed ID: 7516800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methylenedioxyamphetamine (MDA) and methylenedioxymethamphetamine (MDMA) cause selective ablation of serotonergic axon terminals in forebrain: immunocytochemical evidence for neurotoxicity.
    O'Hearn E; Battaglia G; De Souza EB; Kuhar MJ; Molliver ME
    J Neurosci; 1988 Aug; 8(8):2788-803. PubMed ID: 2457659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. (+/-)3,4-Methylenedioxymethamphetamine (MDMA) produces long-term reductions in brain 5-hydroxytryptamine in rats.
    Mokler DJ; Robinson SE; Rosecrans JA
    Eur J Pharmacol; 1987 Jun; 138(2):265-8. PubMed ID: 2887440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro and in vivo neurochemical effects of methylenedioxymethamphetamine on striatal monoaminergic systems in the rat brain.
    Schmidt CJ; Levin JA; Lovenberg W
    Biochem Pharmacol; 1987 Mar; 36(5):747-55. PubMed ID: 2881549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences in the central serotonergic effects of methylenedioxymethamphetamine (MDMA) in mice and rats.
    Stone DM; Hanson GR; Gibb JW
    Neuropharmacology; 1987 Nov; 26(11):1657-61. PubMed ID: 2448703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.